Abstract
The invention relates to a protein comprising at least one immune stimulating domain, at least one hydrophilic random coil domain, and at least one Virus Entry inhibitor (VEI) domain. The invention further relates to a nucleic acid molecule encoding said protein, to an expression construct comprising said nucleic acid molecule, to a pharmaceutical composition comprising the protein, and to methods of producing the protein.
| Original language | English |
|---|---|
| Patent number | WO2019226050 |
| Priority date | 24/05/18 |
| Publication status | Published - 28 Nov 2019 |